Hepatitis A in Western Austria — The epidemiological situation before the introduction of active immunisation

[1]  B. Wiens,et al.  A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. , 1992, The New England journal of medicine.

[2]  C. Kunz,et al.  Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers. , 1990, Vaccine.

[3]  C. Taylor,et al.  Hepatitis A virus antibody in East Anglian blood donors , 1990, The Lancet.

[4]  L. Muylle,et al.  Hepatitis A virus antibodies in Belgium: Relationship between prevalence and age , 1990, Infection.

[5]  Z. Farid,et al.  DIAGNOSIS OF BACTERIAL MENINGITIS , 1989, The Lancet.

[6]  B. Flehmig,et al.  IMMUNOGENICITY OF A KILLED HEPATITIS A VACCINE IN SERONEGATIVE VOLUNTEERS , 1989, The Lancet.

[7]  J. C. Siebke,et al.  Hepatitis A in young Norwegian drug addicts and prison inmates , 1988, Infection.

[8]  S. Iwarson,et al.  Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups. , 1979, American journal of epidemiology.

[9]  C. Kunz,et al.  [The incidence of antibodies to hepatitis A virus in people from Vienna and certain Austrian provinces (author's transl)]. , 1979, Wiener klinische Wochenschrift.

[10]  P. Döller,et al.  Vaccination of adults against travel-related infectious diseases, and new developments in vaccines , 2005, Infection.

[11]  D. R.VranckxPh.,et al.  Hepatitis A virus antibodies in Belgium: Relationship between prevalence and age , 2005, Infection.

[12]  A. Forbes,et al.  Changing epidemiology and clinical aspects of hepatitis A. , 1990, British medical bulletin.

[13]  L. Mathiesen,et al.  Antibody to hepatitis A virus in plasma of Danish blood donors and in immune serum globulin produced in Denmark. , 1980, Scandinavian journal of infectious diseases.